TRLHX
Price
$24.06
Change
+$0.07 (+0.29%)
Updated
Aug 19 closing price
Net Assets
6.33B
VIVIX
Price
$70.65
Change
+$0.33 (+0.47%)
Updated
Aug 19 closing price
Net Assets
195.81B
Interact to see
Advertisement

TRLHX vs VIVIX

Header iconTRLHX vs VIVIX Comparison
Open Charts TRLHX vs VIVIXBanner chart's image
Nuveen Large Cap Value I
Price$24.06
Change+$0.07 (+0.29%)
VolumeN/A
Net Assets6.33B
Vanguard Value Index I
Price$70.65
Change+$0.33 (+0.47%)
VolumeN/A
Net Assets195.81B
TRLHX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
TRLHX vs. VIVIX commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRLHX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 196B vs. TRLHX (6.33B). VIVIX pays higher dividends than TRLHX: VIVIX (2.19) vs TRLHX (1.27). TRLHX was incepted earlier than VIVIX: TRLHX (10 years) vs VIVIX (27 years). TRLHX (0.50) is less costly to investors than VIVIX (0.04). TRLHX is a more actively managed with annual turnover of: 19.00 vs. VIVIX (9.00). TRLHX has a lower initial minimum investment than VIVIX: TRLHX (100000) vs VIVIX (5000000). TRLHX (7.63) and VIVIX (7.59) have marching annual gain over last year. VIVIX return over 5 years is better than : 70.23 vs. TRLHX (55.54).
TRLHXVIVIXTRLHX / VIVIX
Total Expense Ratio0.500.041,250%
Annual Report Gross Expense Ratio0.500.041,250%
Fund Existence10 years27 years-
Gain YTD8.7496.548134%
Front LoadN/AN/A-
Min. Initial Investment10000050000002%
Min. Initial Investment IRAN/AN/A-
Net Assets6.33B196B3%
Annual Yield % from dividends1.272.1958%
Returns for 1 year7.637.59100%
Returns for 3 years21.6427.0480%
Returns for 5 years55.5470.2379%
Returns for 10 yearsN/A127.45-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PDSB1.240.05
+4.20%
PDS Biotechnology Corp
MASI153.930.06
+0.04%
Masimo Corp
TAVIU10.54N/A
N/A
Tavia Acquisition Corp
IMCR32.31-0.57
-1.73%
Immunocore Holdings plc
TNXP40.07-11.28
-21.97%
Tonix Pharmaceuticals Holding Corp